Category Archives: Health

Latest vaccine and world news

Patients wait after receiving their Covid-19 jabs at a vaccination centre at Salisbury Cathedral on February 11, in Salisbury, England. Dan Kitwood/Getty Images

Covid-19 infections in England have fallen by more than two-thirds in recent weeks, initial findings from a survey on community prevalence show. 

The interim findings from the ninth report of REACT-1, a study into Covid-19 infections in England, were released Thursday by Imperial College London.

More than 85,400 volunteers were tested with throat and nose swabs in England between February 4 and 13 to examine the levels of infection in the general population.

The findings show national prevalence fell by two thirds — from 1.57% to 0.51%, or 51 per 10,000 infected. This is a significant decline in infections compared to the last report from January 6 to 22. England entered its third national lockdown of the pandemic on January. 6.

“These encouraging results show that lockdown measures are effectively bringing infections down. It’s reassuring that the reduction in numbers of infections occurred in all ages and in most regions across the country,” Paul Elliott, director of the program at Imperial, said in a statement. 

The decline in prevalence was larger in some regions, in particular in London where it fell from 2.83% to 0.54% since the last report.

“In London, South East and West Midlands, prevalence fell by around 80%, although declines were smaller in the northern regions,” the Imperial report says.

Prevalence fell substantially across all age groups with highest prevalence among 18- to 24-year-olds at 0.89% and those between the ages of 5 and 12 at 0.86%, the report adds. The report concludes that although there is a ” strong decline” in prevalence of coronavirus in England among the general population five to six weeks into lockdown, it still remains high — “at levels similar to those observed in late September 2020.”

There are also still more people hospitalized with Covid-19 than at the peak of the first wave in April 2020.

The UK began its mass vaccination campaign in December, offering nearly all people over 70 a vaccine during January and February. It has now given more than 15 million people a first dose.

“The fall in prevalence was similar among those aged 65 years and over compared with other age groups, suggesting that if vaccines are effective at reducing transmission as well as disease, this effect is not yet a major driver of prevalence trends. Therefore, the observed falls described here are most likely due to reduced social interactions during lockdown,” the report reads.

“We do not yet know whether being vaccinated stops someone from passing the virus on to others,” England’s Department of Health added.

However, on Tuesday the UK Office for National Statistics reported almost 41% of over-80s in England tested positive for antibodies “most likely due to the high vaccination rate in this group.”

Read original article here

Thousands of service members saying no to Covid vaccine

WASHINGTON — By the thousands, U.S. service members are refusing or putting off the Covid-19 vaccine as frustrated commanders scramble to knock down internet rumors and find the right pitch that will persuade troops to get the shot.

Some Army units are seeing as few as one-third agree to the vaccine. Military leaders searching for answers believe they have identified one potential convincer: an imminent deployment. Navy sailors on ships heading out to sea last week, for example, were choosing to take the shot at rates exceeding 80 percent to 90 percent.

Air Force Maj. Gen. Jeff Taliaferro, vice director of operations for the Joint Staff, told Congress on Wednesday that “very early data” suggests that just up to two-thirds of the service members offered the vaccine have accepted.

That’s higher than the rate for the general population, which a recent survey by the Kaiser Family Foundation put at roughly 50 percent. But the significant number of forces declining the vaccine is especially worrisome because troops often live, work and fight closely together in environments where social distancing and wearing masks, at times, are difficult.

The military’s resistance also comes as troops are deploying to administer shots at vaccination centers around the country and as leaders look to American forces to set an example for the nation.

“We’re still struggling with what is the messaging and how do we influence people to opt in for the vaccine,” said Brig. Gen. Edward Bailey, the surgeon for Army Forces Command. He said that in some units just 30 percent have agreed to take the vaccine, while others are between 50 percent and 70 percent. Forces Command oversees major Army units, encompassing about 750,000 Army, Reserve and National Guard soldiers at 15 bases.

At Fort Bragg, North Carolina, where several thousand troops are preparing for future deployments, the vaccine acceptance rate is about 60 percent, Bailey said. That’s “not as high as we would hope for front-line personnel,” he said.

Bailey has heard all the excuses.

“I think the most amusing one I heard was, ‘The Army always tells me what to do, they gave me a choice, so I said no’,” he said.

Service leaders have vigorously campaigned for the vaccine. They have held town halls, written messages to the force, distributed scientific data, posted videos, and even put out photos of leaders getting vaccinated.

For weeks, the Pentagon insisted it did not know how many troops were declining the vaccine. On Wednesday they provided few details on their early data.

Officials from individual military services, however, said in interviews with The Associated Press that refusal rates vary widely, depending on a service member’s age, unit, location, deployment status and other intangibles.

The variations make it harder for leaders to identify which arguments for the vaccine are most persuasive. The Food and Drug Administration has allowed emergency use of the vaccine, so it’s voluntary. But Defense Department officials say they hope that soon may change.

“We cannot make it mandatory yet,” Vice Adm. Andrew Lewis, commander of the Navy’s 2nd Fleet, said last week. “I can tell you we’re probably going to make it mandatory as soon as we can, just like we do with the flu vaccine.”

About 40 Marines gathered recently in a California conference room for an information session from medical staff. One officer, who was not authorized to publicly discuss private conversations and spoke on condition of anonymity, said Marines are more comfortable posing questions about the vaccine in smaller groups.

The officer said one Marine, citing a widely circulated and false conspiracy theory, said: “I heard that this thing is actually a tracking device.” The medical staff, said the officer, quickly debunked that theory, and pointed to the Marine’s cellphone, noting that it’s an effective tracker.

Other frequent questions revolved around possible side effects or health concerns, including for pregnant women. Army, Navy and Air Force officials say they hear much the same.

The Marine Corps is a relatively small service and troops are generally younger. Similar to the general population, younger service members are more likely to decline or ask to wait. In many cases, military commanders said, younger troops say they have had the coronavirus or known others who had it, and concluded it was not bad.

“What they’re not seeing is that 20-year-olds who’ve actually gotten very sick, have been hospitalized or die, or the folks who appear to be fine but then it turns out they’ve developed pulmonary and cardiac abnormalities,” Bailey said.

One ray of hope has been deployments.

Lewis, based in Norfolk, Virginia, said last week that sailors on the USS Dwight D. Eisenhower, which is operating in the Atlantic, agreed to get the shot at a rate of about 80%. Sailors on the USS Iwo Jima and Marines in the 24th Marine Expeditionary Unit, who also are deploying, had rates of more than 90%.

Bailey said the Army is seeing opportunities to reduce the two-week quarantine period for units deploying to Europe if service members are largely vaccinated and the host nation agrees. U.S. Army Europe may cut the quarantine time to five days if 70% of the unit is vaccinated, and that incentive could work, he said.

The acceptance numbers drop off among those who are not deploying, military officials said.

Gen. James McConville, the Army’s chief of staff, used his own experience to encourage troops to be vaccinated. “When they asked me how it felt, I said it was a lot less painful than some of the meetings I go to in the Pentagon.”

Col. Jody Dugai, commander of the Bayne-Jones Army Community Hospital at Fort Polk, Louisiana, said that so far conversations at the squad level, with eight to 10 peers, have been successful, and that getting more information helps.

At the Joint Readiness Training Center at Fort Polk, Brig. Gen. David Doyle, has a dual challenge. As base commander, he must persuade the nearly 7,500 soldiers on base to get the shot and he needs to ensure that the thousands of troops that cycle in and out for training exercises are safe.

Doyle said the acceptance rate on his base is between 30% and 40%, and that most often it’s the younger troops who decline.

“They tell me they don’t have high confidence in the vaccine because they believe it was done too quickly,” he said. Top health officials have attested to the safety and effectiveness of the vaccine.

Doyle said it appears peers are often more influential than leaders in persuading troops — a sentiment echoed by Bailey, the Army Forces Command surgeon.

Read original article here

CDC’s Covid-19 school guidance leaves some reassured, others confused

“That gave us some reassurance around acknowledging that we are making decisions that are going in the right direction,” Herring said.

“There’s still perhaps a bit more that could be beneficial to us as district leaders,” in terms of resources and recommendations, she said.

The guidance comes as the Biden administration aims for more schools to safely reopen.

President Joe Biden said in a CNN town hall with Anderson Cooper on Tuesday night that he wants kindergarten through eighth grade schools open five days a week, and he thinks the nation will be near that goal at the end of his first 100 days in office.

“The loss of being able to be back in school is having a significant impact on the children and parents as well,” Biden said at the town hall in Milwaukee, his first trip outside Washington since taking office.

But not every city in the United States has been willing to open yet.

And in many communities across the country, the CDC guidelines are just the latest data point in arguments between adults who want children back in classrooms now and those hesitant to reopen due to Covid-19 risks.

A race and class debate

“Some of this debate is starting to fall along race and class lines to be honest, and that’s a sign that this equity question continues to dominate the conversation around reopening — and every parent’s perspective is valid,” said Annette Anderson, a professor in the Johns Hopkins University School of Education and deputy director for the Center for Safe and Healthy Schools.
Anderson was referring to how Black and Brown children are impacted more severely by coronavirus, with higher case rates, hospitalizations and virus-complications, leading to more hesitancy among their parents to reopen schools.

“Particularly for families of color, this issue around Covid cases in children is one that has to be resolved,” Anderson said. “So, the more consistent guidance that the CDC can provide in conjunction with other federal agencies over time, it’s going to start building back the trust of those families.”

The CDC guidance recommends that schools limit the spread of Covid-19 by following certain key strategies: mask-wearing, physical distancing, handwashing, keeping classrooms clean and well-ventilated, and contact tracing when someone in the school tests positive for the virus. Vaccines and testing are not among the “key” strategies the agency lays out. They are listed as “additional layers” of Covid-19 prevention.

All of those measures cost money.

The National Education Association told CNN that in order for schools to have the necessary resources to follow these mitigation strategies, the Biden administration’s American Rescue Plan is needed, which includes $170 billion for K-12 school buildings and college campuses. The NEA said that such funding would support ventilation systems, personal protective equipment for students and teachers, among other Covid-19 safety tools.

So for now, some school districts see the guidance as reason to stay open, but other schools — especially if they don’t have the means to implement safety strategies — may view the guidance as a reason to stay closed.

In the Atlanta Public Schools, for instance, third to fifth graders who opted for in-person learning returned last week while sixth to 12th graders who opted for in-person learning returned on Tuesday. The district implemented a surveillance testing program that’s expected to cost up to $13 million for students and staff testing — a program that goes beyond the CDC’s key strategies, and at a cost many districts can’t afford.

Meanwhile, White House Covid-19 response team testing coordinator Carole Johnson outlined on Wednesday a $1.6 billion federal investment focused on testing, of which $650 million in funding will be for testing in schools and underserved populations.

“We need to test broadly and rapidly to turn the tide of this pandemic,” Johnson said during a briefing. “But we still don’t have enough testing and we don’t have enough testing in all the places it needs to be.”

High-risk areas face tough choices

Another point of uncertainty: In most of the country, the spread of Covid-19 is high.

The CDC still says its new guidelines provide strategies for schools to continue in-person learning, even in those Covid-19 transmission “red” zones.

“There can be some confusion there. What the guidelines are saying is that there are a number of things that you can mitigate to make it safer, regardless of what level you’re in,” Dr. Anthony Fauci, President Biden’s chief medical adviser, told CNN’s Jim Sciutto on Tuesday morning.

“If you look at the country, a considerable proportion are in that zone where you really have to be careful because that is a higher risk,” Fauci added.

The CDC told CNN on Monday that about 75% of counties in the United States are currently experiencing high levels of transmission, considered to be “red” zones, while an additional 14% are experiencing “substantial” levels of Covid-19 spread.

A separate CNN analysis has found that a higher percentage — up to 89% — of US children live in a county considered a red zone with high levels of transmission.

“At all levels of community transmission, the strategy provides options for in-person instruction. It is not the case that we are saying that schools that are currently open should close because they are in counties in the ‘red,'” CDC spokesperson Benjamin Haynes told CNN in an email on Monday.

“Our recommendation is that schools in red areas can, in fact, provide in-person instruction, as long as they are strictly implementing mitigation and monitoring cases in the school community.”

The CDC guidelines reference studies that suggest there is a link between levels of community transmission of Covid-19 and risk of the disease spreading to and within schools.

“School administrators, working with local public health officials, should assess the level of risk in the community and the likelihood of a case in a school facility, the likelihood that a case would lead to an outbreak, and the consequences of in-school transmission,” Haynes’ email said.

The National Education Association told CNN on Monday that it agrees with the agency’s argument that preventing Covid-19 in schools is connected to preventing spread in surrounding communities.

“Schools must be prioritized and non-essential businesses should be restricted, if necessary, to bring community rates down to a safer level,” a NEA spokesperson told CNN. “In the end, it will take the necessary resources, political will from leaders and a sense of shared responsibility from everyone in our communities to ensure we can do this safely for students.”

Herring, of Atlanta Public Schools, told CNN that the community plays a role in keeping classrooms Covid-free. “That responsibility is not just within the school but in the community,” she said.

Now the question of what the new CDC guidance means for schools — and communities — remains.

“This is an evolving conversation,” said Anderson of Johns Hopkins University.

“It will be a mistake if we, as a country, do not form this nuanced perspective going into fall of 2021,” Anderson said. “It should be at this point, we have to have an ‘all hands on deck’ approach to get to fall successfully, and we need to establish some benchmarks for what success will look like.”

Teacher vaccinations not required

But there’s already disagreement, too, about the priorities in the guidelines.

Some educators and officials stress that vaccinations should be among the main tools needed to reopen, even though supply is limited around the country. CDC guidance says vaccinations for teachers are not a prerequisite to reopening schools, but rather, an “additional” layer of Covid-19 prevention.

Biden received applause during the CNN town hall on Tuesday night when he said, “I think that we should be vaccinating teachers. We should move them up in the hierarchy as well.”

But the President noted states decide who is eligible for the vaccine, and it varies.

“The states make the decisions on who is in what order,” he said. “I can make recommendations, and for federal programs, I can do that as president of the United States, but I can’t tell the state you must move such-and-such group of people up.”

Nationwide, 28 states and Washington, DC, have started allowing all or some teachers and school staff to receive the Covid-19 vaccine so far. But in other states — such as Georgia, where Herring oversees Atlanta Public Schools — teachers are not yet eligible to receive the vaccine.

“I am a superintendent in Georgia, and I interface with peers across the country and many of them have already had a chance for their educators to be vaccinated,” Herring said, adding that she is worried about educators in her district.

“But as a superintendent who has to advocate for the voices of our teachers and staff, I’ll continue to lift that as a point of opportunity for consideration,” she said. “I know that we’ve been told that vaccination is not required. But much like the surveillance testing, it’s yet another layer to add to mitigation, but it also does something for our mental and psychological wellbeing.”

CNN’s Betsy Klein, Kevin Liptak, Meredith Edwards, DJ Judd and Naomi Thomas contributed to this report.



Read original article here

Serrana, Brazil will vaccinate all adults against Covid-19 to study efficacy on infection rate

The study will involve the city of Serrana, in the southeastern State of Sao Paulo, the research institute said

“The entire adult population, estimated at 30,000 people, will be immunized in three months, in an unprecedented action,” the Butantan Institute wrote via Twitter on Wednesday.

The idea to vaccinate the largest number of people will allow researchers to “follow the evolution of the epidemic. It has technical aspects that will make it possible to make calculations, make projections and calculate whether the vaccine is capable of reducing the transmission of the virus, ” said Dimas Tadeu Covas, the director of the institute.

The city of Serrana, with a population of approximately 45,000, has been divided in four color-coded regions. All people over 18 will be administered a Coronavac vaccine with the exception of pregnant or breastfeeding women and those with serious illnesses, according to the Butantan Institute.

“Based on what we are going to learn here, we will be able to tell the rest of the world what the actual effect of the vaccination against Covid-19 is,” Ricardo Palacios, director of clinical studies at Butantan, said.

Brazil has been hard-hit by the pandemic since it began, and is nearing a total of 10 million Covid-19 cases. The country currently has the most coronavirus related deaths in the world after the US — 242,090 according Johns Hopkins University — and ranks third in the world for cases.

There are rays of hope, Pan American Health Organization Director Dr. Carissa Etienne said on Wednesday. “After many weeks of increases in Covid cases and deaths, we are starting to see improving trends in some of the more heavily affected countries, including the US and Brazil,” she said during a weekly online briefing.

She warned, though, that those trends are “cause for hope, but not for celebration.”

Read original article here

Los Angeles Officials Not Getting Vaccine Projections Biden Promised – Deadline

In January, President Joe Biden promised to provide state and local health officials a three-week window into how many vaccine doses were on the way.

“Until now we’ve had to guess how much vaccine to expect for the next week, and that’s what the governors had to do: ‘How much am I getting next week?’ ” Biden said. “This is unacceptable. Lives are at stake here.”

As of Wednesday, that promise had not yet been fulfilled in the nation’s largest county.

“I don’t have any projections for what we’re getting [in the] next 2-3 weeks out,” said Los Angeles County Public Health director Barbara Ferrer in a call with reporters Wednesday. Not only that, Ferrer revealed that “We’ve been delayed in getting our numbers for next week.”

Substantial Number Of CA Counties Will See Fewer Covid-19 Restrictions

So while Biden promised last month that state and local officials would have a three-week window into their vaccine allotments to allow for site planning and appointment scheduling, one important local official says she doesn’t even have a one-week window.

But California Gov. Gavin Newsom on Wednesday seemed quite clear how many doses would be received the following week, putting the state’s total at 1.3 million doses, slightly up from last week. Newsom did not indicate if he had projections beyond that, but the state determines county allotments from the numbers given to it by the federal government, so the sticking point on next week’s figures seems to be at Newsom’s level.

Beyond that, missing projections may be the federal government’s doing — or not doing.

The governor sought today to “deeply recognize the need to provide more certainty in terms of supply going forward. And that’s exactly what we’re working on with the Biden administration.”

On March 1, Newsom is allowing the next phase of vaccinations to begin. In L.A. County, Ferrer estimated that will mean an additional 1.8 million workers to be vaccinated. To date, the county has administered about 1.5 million first doses and some 400,000 second doses. Given the delta between the two and the supply problems, adding another 1.8 million people to the eligibility roster could sow confusion as the county will likely continue prioritizing second doses before first doses wear off.

Chaos with vaccine distribution and planning have plagued the U.S. vaccine rollout since its inception. Los Angeles had to close its largest vaccination site last weekend because, by Wednesday, it had run out of doses. For two weeks running, the county has delivered mostly second doses because allocation numbers were not only wrong but significantly lower that promised.

“This week we only received 16,000 new doses,” said LA Mayor Eric Garcetti last week after the mega-site at Dodger Stadium closed. “That’s about the number of new doses we give out every single day,” he said. “That is down 90,000 from the week before. That is unacceptable.” Obviously, the city is not getting Biden’s promised three-week window on coming vaccine allocations. And the rapid increase in vaccination sites is not helping.

“It is a little bit of Hunger Games out there,” said Garcetti. “We’re doing kind of an ‘all the above approach.’ I think part of this is we’ve gone to so many places without the supply matching that, that you’ve seen some of the core places…like ours and the county mega sites not have as much supply.”

Asked about healthcare providers “holding back” shots to ensure they’d have a second dose available for each first dose administered, Andy Slavitt, a senior advisor to Biden’s Covid response team, said, “We want to be clear that we understand why health care providers have done that, but that it does not need to happen and should not happen.” That was on February 1.

Slavitt continued, “We completely understand that this has been a direct result of the lack of predictability many states and providers have had regarding how many doses that they would receive,” he said. “That’s one reason why last week we announced that the federal government will be providing a continual three-week window in the vaccines that will be shipped.”

But that window has not opened, and it’s left Angelenos befuddled.

A campaign by Newsom to increase the number of sites offering vaccine has not helped. While the governor’s effort will eventually lead to a vast vaccination network and standardized appointment-making, in the short term it has added yet another layer of bureaucracy for residents to navigate.

The county has a widespread network of vaccination sites. The city administers five more, including the giant Dodger Stadium location. On top of those sit the network of over 100 Rite Aid pharmacies and the state’s own recently announced mega-site at Cal State LA. Then there are the mobile clinics being dispatched to lesser-served neighborhoods. In all, according to county figures, they amount to 391 sites. Each of the entities listed above has its own appointment system. Very few of them actually have first doses on offer.

The county has the capacity for 500,000 appointment slots this week, according to an official statement, however there are only enough doses to distribute less than half that; a little over 211,000 appointments. That means Angelenos not only have to crawl multiple websites and cross reference to find the closest vaccination location, they also have to determine which of those locations actually has doses available.

Newsom launched MyTurn.com to serve as a one-stop shop for appointments, but as of Wednesday searches there were not registering many of the above mentioned sites.

He revealed Wednesday that the state expects 3 million doses per week by March 1 and 4 million per week by April 30, which would flood the aforementioned network with vaccine.

Ferrer seemed hopeful.

“I think we’re going to have a tough month in March,” she said Wednesday, “but things will get better. I think it’s safe to say that, barring some unforeseen calamity, that we will have much more vaccine in April.”



Read original article here

Coronavirus in Oregon: 473 new cases, 5 deaths as most metrics return to October levels

The Oregon Health Authority on Wednesday reported 473 new coronavirus cases and five more deaths.

By most indicators, Oregon has moved past the winter case surge and is reporting its lowest numbers since October.

The state averaged fewer than 400 cases a day in the past week. The rate of positive tests during that span was just 3.3%. Active hospitalizations are now below 200 statewide. And deaths, which trail infections, also are trending down.

Gov. Kate Brown last week relaxed some business restrictions in the metro area because of improving metrics. But state health officials warned that cases may rise again, not only as a result of those changes but also because of more contagious variants silently circulating.

Where the new cases are by county: Baker (5), Benton (7), Clackamas (17), Clatsop (2), Columbia (3), Coos (10), Crook (2), Deschutes (50), Douglas (40), Grant (1), Harney (9), Hood River (6), Jackson (52), Jefferson (10), Josephine (13), Klamath (5), Lake (6), Lane (39), Lincoln (2), Linn (10), Malheur (15), Marion (25), Morrow (2), Multnomah (55), Polk (14), Tillamook (5), Umatilla (11), Union (8), Wallowa (2), Wasco (1), Washington (27) and Yamhill (19).

Who died: Oregon’s 2,139th death linked to COVID-19 is a 72-year-old Jackson County man who tested positive Jan. 26 and died Feb. 14 at Asante Rogue Valley Regional Medical Center.

The 2,140th fatality is a 76-year-old Lincoln County man who tested positive Jan. 28 and died Feb. 15 at Samaritan Pacific Communities Hospital.

Oregon’s 2,141st death is an 89-year-old Marion County woman who tested positive Jan. 15 and died Feb. 12 at her residence.

The 2,142nd fatality is a 53-year-old Multnomah County woman who tested positive Jan. 20 and died Feb. 15 at Legacy Emanuel Medical Center.

Oregon’s 2,143rd death is an 88-year-old Washington County man who became symptomatic Feb. 3 after contact with a confirmed case and died Feb. 12 at his residence.

Each person had underlying health conditions.

The prevalence of infections: The state reported 372 new positive tests out of 11,926 tests performed, equaling a 3.1% positivity rate.

Who got infected: New confirmed or presumed infections grew among the following age groups: 0-9 (30); 10-19 (56); 20-29 (65); 30-39 (41); 40-49 (60); 50-59 (61); 60-69 (33); 70-79 (19); 80 and older (18).

Who’s in the hospital: The state reported 190 Oregonians with confirmed coronavirus infections in the hospital Wednesday, five less than Tuesday. Of those, 44 coronavirus patients are in intensive care units, down seven from Tuesday.

Vaccines: Oregon reported 707,244 doses of vaccine have been administered, or about 77% of the doses received. Oregon reported 15,790 newly administered doses, which includes 10,653 Tuesday and the remainder from previous days.

Since it began: Oregon has reported 151,257 confirmed or presumed infections and 2,143 deaths, among the lowest per capita numbers in the nation. To date, the state has reported 3,431,911 lab reports from tests.

— Brad Schmidt; bschmidt@oregonian.com; 503-294-7628; @_brad_schmidt

Read original article here

Covid-19 Vaccine and Variant News: Live Global Updates

Credit…Kevin Lamarque/Reuters

As lawmakers push for billions of dollars to fund the nation’s efforts to track coronavirus variants, the Biden administration announced on Wednesday a new effort to ramp up this work, pledging nearly $200 million to better identify the emerging threats.

Calling it a “down payment,” the White House said that the investment would result in a significant increase in the number of positive virus samples that labs could sequence. Public health laboratories, universities and programs run by the Centers for Disease Control and Prevention sequenced more than 9,000 genomes last week, according to the database GISAID. The agency hopes to increase its own contribution to 25,000 genomes a week.

“When we will get to 25,000 depends on the resources that we have at our fingertips and how quickly we can mobilize our partners,” Dr. Rochelle Walensky, the C.D.C. director, said at a White House news conference on Wednesday. “I don’t think this is going to be a light switch. I think it’s going to be a dial.”

The program is the administration’s most significant effort to date to address the looming danger of more contagious variants of the virus. A concerning variant first identified in Britain has infected at least 1,277 people in 42 states, although scientists suspect the true number is vastly higher.

Doubling about every 10 days, the B.1.1.7 variant that emerged in Britain threatens to slow or reverse the rapid drop of new coronavirus cases. From a peak of almost 260,000 new cases a day, the seven-day average daily rate has fallen to below 82,000, still well above the high point of last summer’s surge, according to a New York Times database.

What’s more, Dr. Walensky said that the nation had seen its first case of B.1.1.7 that had gained a particularly worrying mutation that has been shown in South Africa to blunt the effectiveness of vaccines.

Other worrisome variants have also cropped up in the United States, including one that was first found in South Africa and weakens vaccines.

The F.D.A. is preparing for a potential redesign of vaccines to better protect against the new variants, but those efforts will take months. In the short term, experts say, it is critical to increase sequencing efforts, which are too small and uncoordinated to adequately track where variants are spreading, and how quickly.

Scientists welcomed the new plans from the Biden administration. “It’s a huge step in the right direction,” said Bronwyn MacInnis, a geneticist at the Broad Institute.

Dr. MacInnis said that the “minimal gold standard” would be sequencing 5 percent of virus samples. If cases continue to fall, then 25,000 genomes a week would put the country near that threshold, she said, which is “where we need to be to be detecting not only known threats, but emerging threats.”

Trevor Bedford, an evolutionary biologist at the Fred Hutchinson Cancer Research Center, said there had been “substantial gains” in national sequencing efforts since December. Still, he said that the C.D.C. would also need to make improvements in gathering data about the genomes — such as tying it to information from contact tracing — and then supporting the large-scale analysis on computers required to quickly make sense of it all.

“There’s too much of a focus on the raw count that we’re sequencing, rather than turnaround time,” he said.

White House officials cast the sequencing ramp-up as part of a broader effort to test more Americans for the virus. The Department of Health and Human Services and the Defense Department on Wednesday announced substantial new investments in testing, including $650 million for elementary and middle schools and “underserved congregate settings,” like homeless shelters. The two departments are also investing $815 million to speed the manufacturing of testing supplies.

The C.D.C.’s $200 million sequencing investment is dwarfed by a program proposed by some lawmakers as part of an economic relief package that Democratic congressional leaders aim to pass before mid-March. Senator Tammy Baldwin, Democrat of Wisconsin, introduced legislation to enhance its sequencing efforts. House lawmakers have allocated $1.75 billion to the effort.


United States › United StatesOn Feb. 16 14-day change
New cases 64,376 –43%
New deaths 1,707 –29%
World › WorldOn Feb. 16 14-day change
New cases 325,121 –28%
New deaths 9,300 –20%

U.S. vaccinations ›

Credit…Doug Mills/The New York Times

When President Biden set a goal last year of 100 million Covid-19 vaccine shots in the first 100 days of his presidency, it now seems that he was aiming low. With the pace of vaccinations quickly rising in the United States, the nation appears likely to get there with more than a month to spare.

About 36.6 million doses have been given in the first four weeks of Mr. Biden’s presidency, bringing the total doses administered to about 56.3 million, as vaccinations have steadily increased since December. The country has averaged 1.64 million doses a day over the last week. (The vaccines that have so far been authorized in the United States involve two doses given several weeks apart, so the number of people who have been fully vaccinated by now is much smaller.)

Mr. Biden said on Tuesday night that the way things are going, vaccines should be available to anyone in the country who wants one “by the end of July,” a timeline made shorter by increasing production and by the prospect that a third vaccine, made by Johnson & Johnson and administered in a single dose, nears authorization.

The White House also said that states will collectively begin receiving 13.5 million doses each week, a jump of more than two million, in part because of a shift in how the doses in each vial of the Pfizer vaccine are being counted. Administration officials have framed regular increases in dose allocations as Mr. Biden’s accomplishment, though supplies were expected to grow as Pfizer and Moderna, the makers of the two authorized vaccines, ramped up manufacturing.

Even if the pace of vaccination stays where it is now, Mr. Biden’s initial goal would be met in late March, around Day 67 of his presidency. If the pace keeps rising and reaches 2 million doses a day, the nation could hit the 100-million-shot mark by Day 60.

“When he first announced it, it did seem like an ambitious goal,” said Dr. Eric Toner, a senior scholar at the Johns Hopkins Center for Health Security. But by Inauguration Day, it was a “low bar,” he said, and now, “something catastrophic would have to happen to keep us from achieving the 100 million doses.”

Mr. Biden first announced the benchmark on Dec. 8, several days before the first shot was given in the country outside of a clinical trial. By the time he was sworn in on Jan. 20, the nation was putting nearly 1 million shots into arms each day, adding to the roughly 19.7 million doses given before he took office.

In all, counting both before and after the change of administration in Washington, about 56.3 million doses have been administered, and about 15.5 million Americans have been fully vaccinated so far, according to data from the Centers for Disease Control and Prevention.

As the president’s initial goal has come within reach, attention has been shifting to the more meaningful challenge of getting vaccine doses to everyone who wants them.

With states expanding their inoculation programs and the federal government gradually expanding supply, Dr. Toner said, the country may be able to administer as many as 3 million doses a day within a few months, twice the pace that Mr. Biden identified in January as a target. That could rein in the spread of the virus to the point that state and local governments could ease restrictions, Dr. Toner said, provided they were careful not to relax too quickly.

“That could get us where we want to go,” he said. “Sometime over the summer, we want life to be looking fairly normal again.”

Noah Weiland contributed reporting.

Credit…Hans Pennink/Associated Press

For months, Assemblyman Ron Kim has been one of the few Democratic lawmakers willing to criticize Gov. Andrew M. Cuomo of New York for his handling of the state’s nursing homes during the pandemic, pressing for investigations into the matter.

Mr. Kim had told the The New York Post last Thursday that it appeared the governor was “trying to dodge having any incriminating evidence” after a top aide to Mr. Cuomo admitted that his administration had withheld nursing home data from state lawmakers.

Hours after he made that comment to the Post, Mr. Kim said Mr. Cuomo called him and yelled at him for 10 minutes. Mr. Kim said the governor threatened to publicly tarnish him if he did not issue a new statement clarifying his remarks.

“He goes off about how I hadn’t seen his wrath and anger, that he would destroy me and he would go out tomorrow and start telling how bad of a person I am and I would be finished and how he had bit his tongue about me for months,” Mr. Kim said. “This was all yelling. It wasn’t a pleasant tone.”

On Wednesday, the governor used his news briefing to lob allegations of impropriety at the assemblyman, saying that he and his administration have had a “long and hostile relationship” with Mr. Kim, now in his fifth term.

Mr. Cuomo accused the assemblyman of a “continuing racket” soliciting donations from nail salon owners, who were upset about a 2015 nail-salon reform law.

A spokesman for the governor, when asked about Mr. Cuomo’s call with Mr. Kim, initially suggested that the governor’s remarks on Wednesday had sufficiently addressed the issue.

But after this article was published, the spokesman, Richard Azzopardi, said that Mr. Cuomo had only asked Mr. Kim to clarify his remarks because the assemblyman had told him that they were taken out of context in the Post article.

Cuomo officials added that the governor never said that he would “destroy” Mr. Kim, and characterized the conversation between the two men as “calm,” denying the governor yelled.

Mr. Cuomo also was angered and combative about a letter published by The New York Post that was signed by several Assembly members, including Mr. Kim. The letter, citing the governor’s delays in releasing a complete tally of deaths of nursing home residents, accused Mr. Cuomo of attempting to circumvent a federal probe and “intentional obstruction of justice.”

Mr. Cuomo has strongly denied any wrongdoing.

Credit…Yamil Lage/Agence France-Presse — Getty Images

The Cuban government says it is on the brink of an extraordinary scientific achievement: the mass production of a coronavirus vaccine invented on the island.

One of the four vaccines developed by Cuban scientists will enter a final phase of testing next month, a crucial step toward regulatory approval that, if successful, could put the island on the path to inoculate its entire population and begin exports by year’s end.

If the vaccine proves safe and effective, it would represent a significant political victory for the Cuban government — and a chance to rescue the nation from economic ruin. For a country that has for decades touted its sophisticated health care system as evidence of the benefits of socialism, the vaccine also offers a unique public relations opportunity.

The vaccine heading for a final phase of trials is called Sovereign 2, in a nod to the pride the island takes in its autonomy, despite decades of hostility from its neighbor to the north. Already, Cuba is floating the idea of enticing tourists to its shores with the irresistible cocktail of sun, sand and a shot of Sovereign 2.

Vicente Vérez, one of the scientists leading the team that developed the vaccine, has said that the island could offer vaccinations to all foreigners who travel there.

Cuban scientists say the government will probably give away some doses to poor countries, in keeping with its longstanding practice of strengthening international relations by donating medicine and sending doctors to address public health crises abroad.

Cuba began to pour money into biotech in the 1980s, as part of Fidel Castro’s drive to make the nation self-sufficient in the face of a U.S. embargo that made it difficult to obtain drugs produced abroad. That investment gave rise to dozens of medical research institutions and a surplus of doctors who can travel on those medical missions.

In 2019, the leasing of doctors, nurses and technicians brought in $5.4 billion, twice as much as tourism, a major driver of the economy.

As for the biotech sector, Cuba makes eight of the 12 vaccines administered to children on the island and exports vaccines to more than 30 countries.

The plan to open Covid-19 vaccination to tourists appears to some to be a risky and shrewdly capitalist gambit to attract visitors, and with them the hard currency the island desperately needs. The combination of the pandemic and sanctions have created the worst economic crisis the country has experienced since the fall of the Soviet Union in the 1990s, experts say.

Cuban scientists, however, insist the goal is to spread health. Any profit, they say, is merely a side effect.

Credit…Paul Sancya/Associated Press

Michigan prison officials said Wednesday that a variant of the coronavirus that is more contagious and potentially more deadly than others has swiftly infected 90 people at a state prison.

The outbreak at the Bellamy Creek Correctional Facility in Ionia is the first in a U.S. prison or jail that is known to involve the variant, called B.1.1.7. Officials said it had not caused any deaths at the prison so far.

The detection of B.1.1.7 at the prison has intensified concerns about the spread of highly transmissible variants in other correctional facilities around the nation, where Covid-19 has caused more than 615,000 infections and nearly 2,800 deaths, according to a New York Times database.

Two of the 90 people at Bellamy Creek who have tested positive for the variant are staff members and 88 are prisoners, Michigan officials said. They said they were awaiting word from the laboratory about whether the variant was present in any of another 100 recent positive tests at the prison.

As of Wednesday morning, officials did not know whether any of the 88 inmates found to be infected with the variant had been vaccinated.

Statewide, about 4,000 Michigan inmates have received coronavirus vaccinations, according to Chris Gautz, a prison spokesman; the state has about 30,000 inmates in all. It is unclear how many Bellamy Creek employees have been vaccinated, he said, because employees are not required to notify the department when they get a shot.

Mr. Gautz said that whenever one of the more than 1,600 prisoners at Bellamy Creek tests positive for the coronavirus, health officials conduct a second test to determine whether the B.1.1.7 variant is responsible. Last week, after detecting the prison’s first variant case, Mr. Gautz said, officials began a regimen of daily testing of employees and staff.

Over the course of the pandemic, about 600 inmates and 100 correctional officers at Bellamy Creek have been infected with the coronavirus so far, and one inmate has died.

Dr. Matthew Wynia, an infectious disease specialist and the director of the Center for Bioethics and Humanities at the University of Colorado, said it was not surprising that the new variant had appeared in a prison, since many states have balked at inoculating inmates before other groups.

“Prisons were generally not put high on the priority list in terms of getting vaccinated, as other congregate settings were,” he said. “So that’s where it’s going to show up.”

Studies have shown that incarcerated people are significantly more likely than others to be infected and to die from the coronavirus. Prisons and jails, Dr. Wynia said, are “petri dishes — they’re designed for the spread of a virus just like this.”

In Michigan, the prison system has offered the vaccine to inmates over the age of 65 and has sometimes given spare doses to younger inmates who have severe underlying health conditions, Mr. Gautz said.

Credit…Tech. Sgt. Anthony Nelson/Department of Defense, via Associated Press

Roughly a third of America’s military personnel are declining to receive coronavirus vaccines when they are offered, Pentagon officials said Wednesday.

The refusal rate is slightly above that of the civilian population, and is the same for active-duty troops and for those in the National Guard, who have been helping state governments administer coronavirus tests and vaccines.

About 960,000 members of the military and its contractors have been vaccinated, Robert G. Salesses, the acting assistant secretary of defense for Homeland Defense and Global Security, told members of the House Armed Services Committee at a hearing on Wednesday. As in the civilian world, the priority for administering vaccinations has been people working in heath care and those over 65.

The Pentagon can require troops to receive standard immunizations, but it cannot make Covid-19 vaccination mandatory, at least for now. That is because the vaccines have been released through federal emergency use authorizations, rather than through the normal, much lengthier approval process. So all the military can do is urge troops to get the shots, not order them to.

“We think it’s important that the department continues to communicate to our service members the safety of the vaccine,” Maj. Gen. Jeff Taliaferro, vice director of operations for the Joint Chiefs of Staff, said at the hearing. He added that troops who decline the vaccine are still permitted to deploy overseas.

For the nation’s entire history, the military has recognized that disease can be far more lethal than an enemy, and it has repeatedly forced troops to be vaccinated. In 1777, George Washington was the first military leader commanding troops to take action to prevent an epidemic by ordering all of his troops to be inoculated against smallpox. That primitive vaccine posed a risk of death. Washington wrote at the time, “This expedient may be attended with some inconveniences and some disadvantages, but yet I trust in its consequences will have the most happy effects.”

In the generations since, the military has mandated troops be vaccinated against a growing list of diseases, including typhoid in 1911, tetanus in 1941, and anthrax in 1997. Today, troops are required to have several other vaccines to travel overseas.

In a recent poll by the Kaiser Family Foundation, 31 percent of respondents from the general public said that they would wait until the vaccine “has been available for a while to see how it is working for other people” before getting the shot themselves. Various news reports and studies have found that refusal rates are highest among Republicans and among Hispanic adults, including many who work in health care.

Defense officials said they were studying the demographics of those in uniform who decline the vaccines, and had reached no conclusions yet.

Most states have relied on National Guard personnel to help respond to the pandemic, including assisting with vaccine distribution and even putting shots in arms.

The Biden administration recently announced that it would open 100 new vaccination sites around the country, operated by the Federal Emergency Management Agency and assisted by hundreds if not thousands of active-duty service members. About 1,100 troops have been deployed at the five centers that have been set up so far.

Dave Philipps contributed reporting.

global roundup

Credit…Koji Sasahara/Associated Press

TOKYO — Japan began its national coronavirus vaccination program on Wednesday, starting with the first of 40,000 medical workers and planning to reach the general population by the summer.

The comparatively late start has raised questions at home and abroad about whether the country will be ready to host the Olympics, which are scheduled to begin in Tokyo this July after the pandemic forced a one-year delay.

Japan has managed to keep coronavirus infection levels relatively low and, so far, has recorded around 7,200 deaths. But the authorities declared a one-month state of emergency in early January, after daily case counts reached nearly 8,000. They have since extended it until at least the beginning of March, partly in response to more contagious coronavirus variants.

The vaccine rollout has been slower than in many other developed countries in part because the authorities requested that Pfizer run separate medical trials in Japan. That reflected some public ambivalence toward vaccinations, a general sense of caution that most recently surfaced after media reports about rare side effects related to vaccines for HPV.

Speaking to the news media on Tuesday, Taro Kono, the minister in charge of the rollout, emphasized that it was important to “show the Japanese people that we have done everything possible to prove the efficacy and safety of the vaccine.”

While that slowed the program’s start, he said, “We think it will be more efficient.”

Major obstacles to a rapid rollout remain. Japan relies on other countries for its entire vaccine supply and is still working to approve the vaccines from AstraZeneca and Moderna. It is also short of the special syringes that would allow its doctors to extract an extra, sixth dose from each vial supplied by Pfizer.

In his remarks on Tuesday, Mr. Kono said the vaccination program was not linked to the Games.

Speaking on Wednesday, the governor of Shimane Prefecture, which has recorded only 280 cases, threatened to pull it out of activities around the Olympic torch relay for fear of spreading infection.

In other developments across the world:

  • President Cyril Ramaphosa of South Africa received the single-dose Johnson and Johnson vaccine on Wednesday, hours after 80,000 doses arrived in the country. Health care workers will be among the first to receive the vaccine. The country paused its rollout of the AstraZeneca vaccine this month after a study suggested that it failed to prevent mild or moderate illness from a variant found in the country. South Africa has recorded nearly 1.5 million coronavirus infections since the start of the pandemic, with 48,855 deaths, according to a New York Times database.

  • The European Commission, the executive arm of the European Union, secured a contract for an additional 300 million doses of the Moderna vaccine, the commission’s president, Ursula von der Leyen, announced on Wednesday. The deal allows European countries to order up to 150 million doses in 2021, with an option for as many next year and authorization to donate unused doses to other countries. The commission, which has been under intense scrutiny following the sluggish vaccination rollout across Europe, had previously signed a contract for 160 million doses.

  • The Gaza Strip received its first 2,000 doses of a coronavirus vaccine on Wednesday after Israel approved their delivery. The Russian-made vaccines were delivered amid a heated debate over whether Israel bears responsibility for the health of Palestinians living in occupied territory.

  • The only things keeping Rio de Janeiro’s famous Carnival faintly alive are the online events produced by groups that traditionally put on extravagant street performances. The celebrations have endured during times of war, violence and the flu, but this year, Covid-19 has forced local officials across Brazil, one of the countries hit hardest by the pandemic, to cancel the festivities.

  • Hong Kong plans to relax restrictions on a range of businesses on Thursday, provided they enforce use of a government-made app for contact tracing or keep records of customers. Employees must also be tested for the coronavirus every two weeks. Separately, on Tuesday, vaccine experts appointed by the Hong Kong government recommended the use of the Sinovac vaccine, a sign that health authorities will approve it for the city’s 7.5 million residents. They approved the Pfizer-BioNTech vaccine in January.

  • Prosecutors in China said that a batch of fake coronavirus vaccines had been shipped outside the country last year, the state-run Xinhua news agency reported on Monday. The fake vaccines were produced by a counterfeiting ring that the authorities broke up in February. Prosecutors said last week that the ring had manufactured and sold about 580,000 vials, for a profit of almost $280 million. The police have also arrested suspects they say smuggled 2,000 vials into Hong Kong, believing them to be genuine. Prosecutors said that 600 of those vaccines were later sent overseas, but did not say where.

  • Health authorities in Germany have documented rapid growth in the more infectious coronavirus variant first found in Britain, despite a general drop in new infections during a monthslong lockdown. Jens Spahn, the German health minister, said during a news conference on Wednesday that the variant now accounted for 22 percent of tested coronavirus samples, up from 6 percent at the beginning of February.

Credit…National Institute of Allergy and Infectious Diseases, via Getty Images

In an attempt to learn more about how a person’s immune system responds to the coronavirus, researchers will purposefully administer the virus in the coming weeks to a small group of carefully selected volunteers in a London hospital.

As many as 90 people from ages 18 to 30 could be a part of the plan that was authorized by British regulators on Wednesday. Tiny droplets of the virus will be administered into the nostrils of unvaccinated volunteers to deliberately infect them with the coronavirus.

By controlling the amount of the virus people are subjected to and monitoring them from the moment they are infected, scientists are hoping to discover things about how the immune system responds to the coronavirus that would be impossible outside a lab — and to develop ways of directly comparing the efficacy of treatments and vaccines.

Scientists hope to eventually expose vaccinated people to the virus as a way of comparing the effectiveness of different vaccines. But before that, the project’s backers have to expose unvaccinated volunteers in order to determine the lowest dose of the virus that will reliably infect them.

“We are going to learn an awful lot about the immunology of the virus,” Peter Openshaw, an Imperial College London professor involved in the study, said on Wednesday. He added that the study would be able “to accelerate not only understanding of diseases caused by infection, but also to accelerate the discovery of new treatments and of vaccines.”

The idea of such a study, called a human challenge trial, has been hotly debated since the early months of the pandemic.

In the past, scientists have deliberately exposed volunteers to diseases like typhoid and cholera to test vaccines. But infected people could be cured of those diseases; Covid-19 has no known cure, putting the scientists in charge of the British study in largely uncharted ethical territory.

But there have been severe Covid-19 cases even in young patients — the group being infected — and the long-term consequences of an infection are also largely unknown. The study’s age range may also make it difficult to translate its findings to older adults or people with pre-existing conditions, whose immune responses may be different.

“It will be a limited study,” said Ian Jones, a professor of virology at the University of Reading who is not part of the study. “And you could argue that, by definition, it’s not going to study those in whom it’s most important to know what’s going on.”

Credit…Karsten Moran for The New York Times

Gov. Andrew M. Cuomo of New York announced on Wednesday that outdoor amusement parks, indoor entertainment centers and summer camps would be able to reopen, with restrictions, in the coming months, even though coronavirus cases and deaths in the state remain high.

Mr. Cuomo said that indoor entertainment centers could open at 25 percent capacity on March 26; outdoor amusement parks could reopen at 33 percent capacity on April 9, with tickets sold in advance; and summer camps could plan on reopening in June.

Temperature checks and face coverings would be required at amusement parks and centers, and attractions where social distancing or easy, frequent cleaning were not possible would remain closed. Testing protocols will be required for summer camps.

“No parent is going to send their child to a summer camp unless there is a testing protocol anyway,” Mr. Cuomo said on a phone call with reporters on Wednesday.

The governor said that the reopening plans were contingent on virus cases’ continuing to drop in the state, and described current trends as encouraging. He said that New York’s seven-day average positive test rate was at 3.6 percent, the lowest it has been since late November. But at the same time, in the past two weeks, the state has had more cases and deaths per capita than any state except South Carolina, according to a New York Times database.

More contagious variants of the virus still posed a threat, the governor said, particularly one that was first discovered in Britain. Mr. Cuomo said that 82 cases of the variant had been discovered in New York, with 12 new ones confirmed since Saturday.

He also announced that in the first week of March the state would open four more mass vaccination sites in partnership with the federal government, like the two that are set to open in Brooklyn and Queens. The sites, at the New York National Guard Armory in Yonkers, the Delavan Grider Community Center in Buffalo, the Washington Avenue Armory in Albany and a parking lot near the former Kodak Hawkeye building in Rochester, are intended for underserved communities. Each will aim to vaccinate 1,000 people a day, he said.

“It is very important that the distribution be fair,” Mr. Cuomo said. “This is a precious resource; everybody wants it.”

The governor said that vaccine distribution would be impaired by the winter storms that have battered the country this week.

Mayor Bill de Blasio of New York City said on Wednesday that storms had delayed shipments of the vaccine and prevented officials from scheduling 30,000 to 35,000 vaccination appointments.

Video

transcript

transcript

Winter Storm Delayed Vaccine Shipments to N.Y.C., Mayor Says

Mayor Bill de Blasio said dangerous winter weather across the country had delayed Covid-19 vaccine shipments to New York and prevented officials from scheduling 30,000 to 35,000 appointments.

“We’ve got fewer than 30,000 first doses on hand right now. That means we’re going to run out today, tomorrow. We’re going to run out of what we have now. Once again, we’re in this ridiculous situation. We have massive ability to give people vaccination. We could be doing hundreds of thousands of more each week. And we’re running out of vaccine because we’re not getting what we need.” “And on top of that, we’ve got the weather problem. All over the nation, there’s huge storms that are now causing delays in shipments. So I’ve been updated this morning on the fact that we unfortunately do expect vaccine to be delayed, shipments of vaccine that we were expecting by yesterday, today, to be delayed. That means we’re going to have to hold back appointments that New Yorkers need because the vaccine isn’t arriving. Based on the information I’ve got now, as many as 30, 35,000 appointments or more might not be scheduled because we don’t have vaccine. So, appointments we would have been putting up, available to people right now, we have to hold them back because the vaccine hasn’t arrived.”

Mayor Bill de Blasio said dangerous winter weather across the country had delayed Covid-19 vaccine shipments to New York and prevented officials from scheduling 30,000 to 35,000 appointments.CreditCredit…Kirsten Luce for The New York Times

The dangerous winter weather has delayed shipments of vaccine doses to New York City, Mayor Bill de Blasio said on Wednesday, preventing officials from scheduling between 30,000 and 35,000 new vaccination appointments, delaying the opening of two new vaccination sites, and complicating a rollout already constrained by a limited supply of doses.

The problems in New York City, which could extend to suburbs and neighboring states, came as vaccination efforts have been disrupted nationwide. Clinics have closed and shipments have been stalled as snow and ice grounded flights and made highways dangerously slick. Many of the closures and cancellations have been in the South, where the storm hit hardest, with Texas, Alabama, Georgia and Kentucky canceling or rescheduling appointments.

Jeffrey D. Zients, President Biden’s coronavirus response coordinator, said on Wednesday that the Biden administration was pushing governors to extend the hours of vaccination sites once they reopen.

“People are working as hard as they can, given the importance of getting the vaccines to the states and to providers, but there’s an impact on deliveries,” he said.

Mr. de Blasio said he did not know when the shipments would arrive next or which specific weather conditions were snarling the shipments.

New vaccination sites in Queens and on Staten Island would not open on Thursday as scheduled because of the delays, the mayor said in a statement on Wednesday night, calling on pharmaceutical companies to solve supply problems. “Step up and give us the doses we need to vaccinate the people of our city,” he said. “There is not a moment to waste.”

In New York City, like other places across the country, the demand for vaccinations far outstrips the supply allocated each week. Mr. de Blasio said that the city had about 30,000 doses on hand, and that those could run out by Thursday.

“We could be doing hundreds of thousands more each week,” he said.

A heavy snowstorm this month forced city and state officials to delay appointments for days until driving conditions improved, and New York is expecting about six inches of snow on Thursday.

Credit…Doug Mills/The New York Times

The commander of the U.S. base at Guantánamo Bay, Cuba, shut down most community activities at the base overnight Tuesday, barring dining in restaurants and closing gyms and the school for sailors’ children after some residents tested positive for the coronavirus at the isolated post.

Clergy members marking Ash Wednesday held a “drive-through distribution of ashes” in the chapel parking lot, near the base’s McDonalds restaurant, which switched overnight to takeout only.

The closures are “a precautionary measure after a small number of personnel tested positive for Covid-19,” said Nikki L. Maxwell, a base spokeswoman. Those who tested positive and people who may have come in contact with them were in quarantine as of Wednesday night. More testing was underway.

The last time the base took similar action was in October, after someone at the base initially tested positive for the virus. Community activities were restricted for 10 days while health officials conducted new tests and sent samples to the mainland United States for analysis. The case turned out to be a false positive.

A base-wide notice to the base’s 6,000 residents said the latest restrictions would be temporary, but offered no specifics. Saying that the impacts of the closures “on our personnel, family members, services and daily life are understood,” the notice thanked residents for their “enduring patience and support.”

Health workers at Guantánamo have been offering residents the Moderna vaccine in phases for more than a month. Shuttle bus drivers, commissary workers, schoolteachers, intelligence analysts, bartenders and Marines who guard the fence line separating the base from a Cuban minefield are among those now eligible for shots.

After a public outcry, the Pentagon postponed plans to vaccinate the 40 wartime prisoners who are held in a restricted area at the base. The 1,500 troops who staff the detention facility have been offered vaccination, according to a spokesman for the U.S. Southern Command. The military has declined to say how many of those troops, mostly National Guard soldiers on nine-month rotations, accepted the offer.

Covid-19 vaccinations are voluntary for Department of Defense personnel because the vaccines are being distributed under an emergency use authorization.

Guantánamo Bay reported two confirmed cases of residents with coronavirus in March and April, before the Pentagon curbed disclosures of the number of cases at individual bases. Both people were put in isolation and recovered, the military said.

The Navy requires everyone arriving at the base to be quarantined for two weeks.



Read original article here

If This Is in Your Blood, You May Be Safe You From Severe COVID

While masking, social distancing, and getting vaccinated as soon as possible are all good ways to lower your chances of catching COVID, new research suggests that there’s a certain genetic factor that may mitigate your risk of developing more severe COVID symptoms. According to a new study conducted by researchers at the Okinawa Institute of Science and Technology Graduate University, a particular DNA marker may keep a person safe from a severe case of COVID that merits hospitalization. Read on to discover what the researchers found and how it could affect you. And if you want to protect yourself, know that If You’re Layering These Masks, the CDC Says to Stop Immediately.

Shutterstock

In the new study, which will be published in the March 2021 volume of PNAS, researchers discovered that a particular group of Neanderthal genes—specifically those affecting chromosome 12—that still exist in individuals today can help reduce a person’s risk of having a case of COVID that necessitates intensive care treatment by 22 percent.

“Despite Neanderthals becoming extinct around 40,000 years ago, their immune system still influences us in both positive and negative ways today,” geneticist and study co-author Svante Pääbo, PhD, explained in a statement. And for the latest COVID news delivered right to your inbox, sign up for our daily newsletter.

iStock

The study’s authors discovered that the particular genetic variant passed down from the Neanderthal DNA was capable of reducing the severity of COVID through a specific mechanism. This particular genetic factor—which has been identified in three Neanderthals running the gamut from 50,000 years old to 120,000 years old—spurs the production of virus-fighting enzymes within the human body. “It seems that the enzymes encoded by the Neanderthal variant are more efficient, reducing the chance of severe consequences to SARS-CoV-2 infections,” said Pääbo. And if you want to stay safe when you’re out of the house, beware that The CDC Just Issued a Warning About This Kind of Face Mask.

Shutterstock

The study’s researchers found that the genetic variant is widespread throughout much of the world. “It is present in populations in Eurasia and the Americas at carrier frequencies that often reach and exceed 50 percent,” according to the PNAS study.

In Japan, around 30 percent of individuals bear the genetic trait, while the study’s researchers found it to be “almost completely absent” in sub-Saharan Africa. And for more on what could keep you safe you from severe COVID, check out This Common Medication Could Slash Your Risk of COVID Death, Study Says.

Shutterstock

While the identified Neanderthal DNA variant may offer some protection to those who have it, it won’t necessarily cancel out other risk factors for developing severe COVID. “Of course, other factors such as advanced age or underlying conditions such as diabetes have a significant impact on how ill an infected individual may become,” explained Pääbo. “But genetic factors also play an important role and some of these have been contributed to present-day people by Neanderthals.” And if you’ve got your vaccine appointment, know that The CDC Is Warning You Not to Do This Right Before You Get Vaccinated.

Read original article here

Pfizer says South African variant could significantly reduce vaccine protection

A vaccination tray of Pfizer BioNtech vaccines.

Matthias Bein | picture alliance | Getty Images

A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer/BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.

The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.

Still, they are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed.

For the study, scientists from the companies and the University of Texas Medical Branch (UTMB) developed an engineered virus that contained the same mutations carried on the spike portion of the highly contagious coronavirus variant first discovered in South Africa, known as B.1.351. The spike, used by the virus to enter human cells, is the primary target of many Covid-19 vaccines.

Researchers tested the engineered virus against blood taken from people who had been given the vaccine, and found a two-thirds reduction in the level of neutralizing antibodies compared with its effect on the most common version of the virus prevalent in U.S. trials.

Their findings were published in the New England Journal of Medicine (NEJM).

Because there is no established benchmark yet to determine what level of antibodies are needed to protect against the virus, it is unclear whether that two-thirds reduction will render the vaccine ineffective against the variant spreading around the world.

However, UTMB professor and study co-author Pei-Yong Shi said he believes the Pfizer vaccine will likely be protective against the variant.

“We don’t know what the minimum neutralizing number is. We don’t have that cutoff line,” he said, adding that he suspects the immune response observed is likely to be significantly above where it needs to be to provide protection.

That is because in clinical trials, both the Pfizer/BioNTech vaccine and a similar shot from Moderna Inc conferred some protection after a single dose with an antibody response lower than the reduced levels caused by the South African variant in the laboratory study.

Even if the concerning variant significantly reduces effectiveness, the vaccine should still help protect against severe disease and death, he noted. Health experts have said that is the most important factor in keeping stretched healthcare systems from becoming overwhelmed.

More work is needed to understand whether the vaccine works against the South African variant, Shi said, including clinical trials and the development of correlates of protection – the benchmarks to determine what antibody levels are protective.

Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil.

Moderna published a correspondence in NEJM on Wednesday with similar data previously disclosed elsewhere that showed a sixfold drop antibody levels versus the South African variant.

Moderna also said the actual efficacy of its vaccine against the South African variant is yet to be determined. The company has previously said it believes the vaccine will work against the variant.

Read original article here

Pfizer, Moderna vaccines can protect against coronavirus variant, lab studies suggest

For the study, researchers at Pfizer and the University of Texas Medical Branch genetically engineered versions of the virus to carry some of the mutations found in B.1.351. They tested them against blood samples taken from 15 people who had received two doses of the Pfizer/BioNTech vaccine as part of a clinical trial.

While the blood serum samples produced less neutralizing antibody activity, it was still enough to neutralize the virus, they wrote in a letter to the journal. This is in line with other studies. And it’s well within what is seen with other viruses, one of the researchers said.

“Although we do not yet know exactly what level of neutralization is required for protection against COVID-19 disease or infection, our experience with other vaccines tells us that it is likely that the Pfizer vaccine offers relatively good protection against this new variant,” Scott Weaver, director of the Institute for Human Infections and Immunity at the University of Texas Medical Branch and an author of the study, told CNN.

“The reduction in the levels of neutralization against the South African variant of about 2/3 is fairly small compared to variations in neutralization levels generated by vaccines against other viruses that have even more variability in their protein sequences than SARS-CoV-2,” Weaver added.

Pfizer said there is no evidence in real life that the variant escapes the protection offered by its vaccine. “Nevertheless, Pfizer and BioNTech are taking the necessary steps, making the right investments, and engaging in the appropriate conversations with regulators to be in a position to develop and seek authorization for an updated mRNA vaccine or booster once a strain that significantly reduces the protection from the vaccine is identified,” Pfizer said in a statement.

Separately, a team at the National Institutes of Health and Moderna published a letter in the same journal outlining findings from an experiment they reported last month. They also reported a reduction in the antibody response to viruses genetically engineered to look like the B.1.351 variant — but not enough of a reduction to make the vaccine work any less effectively.

“Despite this reduction, neutralizing titer levels with (the variant discovered in South Africa) remain above levels that are expected to be protective,” the company said in a statement.

They found no reduction in efficacy against a variant first seen in the UK and known as B.1.1.7.

Read original article here